PEGASUS™ is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. Surrogate assays ...
1910 is on a mission to “make undruggable targets a thing of the past” by “turning every pharma company into an AI company,” says founder and CEO, Jen Asher, PhD. The Sam Altman–backed AI drug ...
1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today announced the publication of PEGASUS™, a multimodal AI model that achieves state-of-the-art accuracy ...
The MarketWatch News Department was not involved in the creation of this content. -- PEGASUS(TM) is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable ...
The MarketWatch News Department was not involved in the creation of this content. -- PEGASUS(TM) is an industry-first in peptide design: It achieves AI-driven generative design of the first permeable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results